| Literature DB >> 33668893 |
Mehmet Abdullah Alagöz1, Zeynep Özdemir1, Mehtap Uysal2, Simone Carradori3, Marialucia Gallorini3, Alessia Ricci3, Susi Zara3, Bijo Mathew4.
Abstract
Novel twenty-three 3(2H)-pyridazinone derivatives were designed and synthesized based on the chemical requirements related to the anti-proliferative effects previously demonstrated within this scaffold. The introduction of a piperazinyl linker between the pyridazinone nucleus and the additional (un)substituted phenyl group led to some compounds endowed with a limited cytotoxicity against human gingival fibroblasts (HGFs) and good anti-proliferative effects against gastric adenocarcinoma cells (AGS) as evaluated by MTT and LDH assays, using doxorubicin as a positive control. Successive analyses revealed that the two most promising representative compounds (12 and 22) could exert their effects by inducing oxidative stress as demonstrated by the hydrogen peroxide release and the morphological changes (cell blebbing) revealed by light microscopy analysis after the haematoxylin-eosin staining. Moreover, to further assess the apoptotic process induced by compounds 12 and 22, Bax expression was measured by flow cytometry. These findings enlarged our knowledge of the structural requirements in this scaffold to display valuable biological effects against cancerous cell lines.Entities:
Keywords: 3(2H)−pyridazinone; Bax; H2O2 release; fibroblasts; gastric cancer; hydrazone; piperazine
Year: 2021 PMID: 33668893 PMCID: PMC7996573 DOI: 10.3390/ph14030183
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247